These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 35969920)

  • 1. COVID-19 and the opportunity for gender-responsive virtual and remote substance use treatment and harm reduction services.
    Perri M; Schmidt RA; Guta A; Kaminski N; Rudzinski K; Strike C
    Int J Drug Policy; 2022 Oct; 108():103815. PubMed ID: 35969920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. "You know, we can change the services to suit the circumstances of what is happening in the world": a rapid case study of the COVID-19 response across city centre homelessness and health services in Edinburgh, Scotland.
    Parkes T; Carver H; Masterton W; Falzon D; Dumbrell J; Grant S; Wilson I
    Harm Reduct J; 2021 Jun; 18(1):64. PubMed ID: 34118942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harm Reduction for Adolescents and Young Adults During the COVID-19 Pandemic: A Case Study of Community Care in Reach.
    Noyes E; Yeo E; Yerton M; Plakas I; Keyes S; Obando A; Gaeta JM; Taveras EM; Chatterjee A
    Public Health Rep; 2021 May; 136(3):301-308. PubMed ID: 33673755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.
    Stowe MJ; Calvey T; Scheibein F; Arya S; Saad NA; Shirasaka T; Dannatt L; Ghosh A; Yee A; Ratta-Apha W; Vadivel R; Siste K; Shah B; Ramalho R; Narasimha VL; Delic M; Peyron E; Onoria JLG; Pant SB; Boujraf S; Grandinetti P; Morgan N
    J Addict Med; 2020 Dec; 14(6):e287-e289. PubMed ID: 33009167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Going virtual: youth attitudes toward and experiences of virtual mental health and substance use services during the COVID-19 pandemic.
    Hawke LD; Sheikhan NY; MacCon K; Henderson J
    BMC Health Serv Res; 2021 Apr; 21(1):340. PubMed ID: 33853602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BeHERE's effective virtual training to build capacity to support people who use drugs in non-substance use disorder settings.
    Kenefick HW; Wing A
    Harm Reduct J; 2024 Feb; 21(1):38. PubMed ID: 38351012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for remote delivery of behavioral economic interventions for substance use disorder during COVID-19 and beyond.
    Coughlin LN; Bonar EE; Bickel WK
    J Subst Abuse Treat; 2021 Jan; 120():108150. PubMed ID: 33298296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Remote harm reduction services are key solutions to reduce the impact of COVID-19-like crises on people who use drugs: evidence from two independent structures in France and in the USA.
    Torres-Leguizamon M; Favaro J; Coello D; Reynaud EG; Néfau T; Duplessy C
    Harm Reduct J; 2023 Jan; 20(1):1. PubMed ID: 36611167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of COVID-19 among people who use drugs: A qualitative study with harm reduction workers and people who use drugs.
    Conway FN; Samora J; Brinkley K; Jeong H; Clinton N; Claborn KR
    Harm Reduct J; 2022 Jul; 19(1):72. PubMed ID: 35780109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Preferences of Transgender and Nonbinary People for Virtual Health Care After the COVID-19 Pandemic in Canada: Cross-sectional Study.
    Navarro JM; Scheim AI; Bauer GR
    J Med Internet Res; 2022 Oct; 24(10):e40989. PubMed ID: 36170497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Women and barriers to harm reduction services: a literature review and initial findings from a qualitative study in Barcelona, Spain.
    Shirley-Beavan S; Roig A; Burke-Shyne N; Daniels C; Csak R
    Harm Reduct J; 2020 Oct; 17(1):78. PubMed ID: 33076931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges and opportunities during the COVID-19 pandemic: Treating patients for substance use disorders during the perinatal period.
    Jones HE; Hairston E; Lensch AC; Marcus LK; Heil SH
    Prev Med; 2021 Nov; 152(Pt 2):106742. PubMed ID: 34302836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons from the COVID-19 pandemic for substance misuse services: findings from a peer-led study.
    Holloway K; Murray S; Buhociu M; Arthur A; Molinaro R; Chicken S; Thomas E; Courtney S; Spencer A; Wood R; Rees R; Walder S; Stait J
    Harm Reduct J; 2022 Dec; 19(1):140. PubMed ID: 36503439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Addressing the complex substance use and mental health needs of people leaving prison: Insights from developing a national inventory of services in Canada.
    Watson TM; Benassi PV; Agic B; Maharaj A; Sockalingam S
    Int J Drug Policy; 2022 Feb; 100():103523. PubMed ID: 34785421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the COVID-19 pandemic on harm reduction services in Catalonia: the experience of people who use drugs and harm reduction professionals.
    Bosch-Arís M; Gasulla L; de Gispert T; Segura L; Colom J
    Harm Reduct J; 2022 Oct; 19(1):118. PubMed ID: 36289531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Finding opportunity in the COVID-19 crisis: prioritizing gender in the design of social protection policies.
    Perri M; Metheny N; Matheson FI; Potvin K; O'Campo P
    Health Promot Int; 2022 Feb; 37(1):. PubMed ID: 33993289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.